Albumin changes as early signs of chronic liver disease
Treatments studied
Part of Digestive system clinical trials.
This study is looking at whether changes in a protein called albumin can help find liver disease earlier. It is for people who have some liver scarring but no serious complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have liver scarring (fibrosis) that measured 10 kPa or higher on a FibroScan test.
- You had a blood test at the hospital as part of your regular care.
- You do not have severe liver disease with complications (decompensated cirrhosis).
- You have not had an albumin infusion in the past month.
- You do not have advanced kidney disease, cancer, or are pregnant/breastfeeding (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at non-invasive tests (tests that don’t require surgery) to see whether they can diagnose and predict how chronic liver disease will worsen over time. If you may have chronic liver disease, these tests could help doctors follow your condition more accurately.
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
This trial tests whether a personalized long-term albumin (a blood protein medicine) can help people with advanced liver scarring who have fluid in the belly (ascites). It compares the personalized albumin approach to standard care to see if it improves outcomes over time.
This study looks at how blood clotting, inflammation, and blood vessels change in people with chronic liver disease or cirrhosis. Your blood tests may help researchers understand what drives the disease and could guide future care.
This study tests whether giving a common fluid (albumin) early can help protect the kidneys in people with advanced liver disease who have a sudden kidney injury. It aims to see if this simple treatment can improve recovery and prevent the need for dialysis.
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
Hear when a new Chronic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.